These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25359093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
    Lyu JJ, Kong YY, Cai X, Shen XX, Lu YW, Ren M.
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug 08; 46(8):548-552. PubMed ID: 28810295
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
    Ilie MI, Long-Mira E, Hofman V, Mouroux J, Vignaud JM, Gauchotte G, Begueret H, Merlio JP, Emile JF, Hébuterne X, Hofman P.
    Pathology; 2014 Jun 08; 46(4):311-5. PubMed ID: 24798160
    [Abstract] [Full Text] [Related]

  • 9. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
    Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A.
    Acta Neuropathol; 2011 Jul 08; 122(1):11-9. PubMed ID: 21638088
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.
    Anwar MA, Murad F, Dawson E, Abd Elmageed ZY, Tsumagari K, Kandil E.
    J Surg Res; 2016 Jun 15; 203(2):407-15. PubMed ID: 27363650
    [Abstract] [Full Text] [Related]

  • 11. Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma.
    Thiel A, Moza M, Kytölä S, Orpana A, Jahkola T, Hernberg M, Virolainen S, Ristimäki A.
    Hum Pathol; 2015 Feb 15; 46(2):169-75. PubMed ID: 25442222
    [Abstract] [Full Text] [Related]

  • 12. Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility.
    Marin C, Beauchet A, Capper D, Zimmermann U, Julié C, Ilie M, Saiag P, von Deimling A, Hofman P, Emile JF.
    Arch Pathol Lab Med; 2014 Jan 15; 138(1):71-5. PubMed ID: 23651150
    [Abstract] [Full Text] [Related]

  • 13. BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.
    Kakavand H, Walker E, Lum T, Wilmott JS, Selinger CI, Smith E, Saw RP, Yu B, Cooper WA, Long GV, O'Toole SA, Scolyer RA.
    Histopathology; 2016 Oct 15; 69(4):680-6. PubMed ID: 27151331
    [Abstract] [Full Text] [Related]

  • 14. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
    Uguen A, Talagas M, Costa S, Samaison L, Paule L, Alavi Z, De Braekeleer M, Le Marechal C, Marcorelles P.
    Diagn Pathol; 2015 Jul 25; 10():121. PubMed ID: 26204954
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
    Kuan SF, Navina S, Cressman KL, Pai RK.
    Hum Pathol; 2014 Mar 25; 45(3):464-72. PubMed ID: 24529329
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
    Hayashi Y, Sasaki H, Takeshita S, Nishikawa R, Nishikawa H, Arakawa A, Yamashita Y, Takahashi S, Sugiura-Ogasawara M.
    Oncol Rep; 2014 Nov 25; 32(5):1815-9. PubMed ID: 25174456
    [Abstract] [Full Text] [Related]

  • 17. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
    Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL.
    Hum Pathol; 2015 Aug 25; 46(8):1101-10. PubMed ID: 26058727
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
    Dvorak K, Higgins A, Palting J, Cohen M, Brunhoeber P.
    Pathol Oncol Res; 2019 Jan 25; 25(1):349-359. PubMed ID: 29127628
    [Abstract] [Full Text] [Related]

  • 19. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
    Estrella JS, Tetzlaff MT, Bassett RL, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR.
    Mol Cancer Ther; 2015 Dec 25; 14(12):2887-95. PubMed ID: 26438153
    [Abstract] [Full Text] [Related]

  • 20. BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods.
    O'Brien O, Lyons T, Murphy S, Feeley L, Power D, Heffron CCBB.
    J Clin Pathol; 2017 Nov 25; 70(11):935-940. PubMed ID: 28424234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.